tafasitamab

Italy

Drugs containing this active substance

  • MINJUVI

    It is used for the treatment of adults with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) that have relapsed after previous treatment or have not responded to previous therapies.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    tafasitamab -

    ATC: L01FX12

    Manufacturer: INCYTE BIOSCIENCES DISTRIBUTION B.V.